MLSS — Milestone Scientific Income Statement
0.000.00%
Last trade - 00:00- $85.43m
- $82.24m
- $8.63m
- 52
- 10
- 83
- 46
Annual income statement for Milestone Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5.44 | 10.3 | 8.81 | 9.83 | 8.63 |
| Cost of Revenue | |||||
| Gross Profit | 3.62 | 6.31 | 4.9 | 6.79 | 6.43 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 12.9 | 17.4 | 17.6 | 16.9 | 13.4 |
| Operating Profit | -7.45 | -7.1 | -8.83 | -7.11 | -4.77 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -7.47 | -7.12 | -8.77 | -6.98 | -4.71 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -7.49 | -7.12 | -8.77 | -6.98 | -4.71 |
| Minority Interest | |||||
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -7.34 | -6.82 | -8.71 | -6.93 | -4.71 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -7.34 | -6.82 | -8.71 | -6.93 | -4.71 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.116 | -0.102 | -0.123 | -0.095 | -0.084 |